Genistein inhibits NF-κB activation in prostate cancer cells

Nutrition and Cancer

Volumn 35, Issue 2, 1999, Pages 167-174

  Davis, Joanne N ^a   Kucuk, Omer ^b   Sarkar, Fazlul H ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

EID: 0033509354     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC352_11     Document Type: Article

References (38)

1. Adlercreutz, H, Markkanen, H, and Watanabe, S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210, 1993.
2. Morton, MS, Wilcox, G, Wahlqvist, ML, and Griffiths, K: Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142, 251-259, 1994.
3. Herbert, J, Hurley, T, Olendzki, B, Teas, J, Yunsheng, M, et al.: Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. JNCI 90, 1637-1647, 1998.
4. WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 32, 123-131, 1998.
5. Peterson, G, and Barnes, S: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179, 661-667, 1991.
6. 2/M arrest and apoptosis. J Cell Biochem 69, 44-54, 1998.
7. WAF1 upregulation, and apoptosis in a non-small cell lung cancer cell line. Nutr Cancer 31, 184-191, 1998.
8. Akiyama, T, Ishida, J, Nakagawa, S, Ogawara, H, Watanabe, S, et al.: Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 262, 5592-5595, 1987.
9. Okura, A, Arakawa, H, Oka, H, Yoshinari, T, and Monden, Y: Effect of genistein on topoisomerase activity and on the growth of [val 12] Ha-ras transformed NIH 3T3 cells. Biochem Biophys Res Commun 157, 183-189, 1998.
10. Huang, J, Nasr, M, Kim, Y, and Matthews, HR: Genistein inhibits protein histidine kinase. J Biol Chem 267, 15511-15515, 1992.
11. Fotsis, T, Pepper, M, Adlercreutz, H, Fleischmann, G, Hase, T, et al.: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90, 2690-2694, 1993.
12. Sen, R, and Baltimore, D: Inducibility of K immunoglobulin enhancer-binding protein NF-κB by a post-translational event. Cell 47, 921-928, 1986.
13. Baeuerle, P, and Henkel, T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12, 141-179, 1994.
14. Miyamoto, S, and Verma, IM: Rel/NF-κB/κB story. Adv Cancer Res 66, 255-287, 1995.
15. Wu, M, Lee, H, Bellas, R, Schauer, S, Arsura, M, et al.: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15, 4682-4690, 1996.
16. Beg, A, Sha, W, Bronson, R, Ghosh, S, and Baltimore, D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170, 1995.
17. Wang, C, Mayo, M, and Baldwin, A, Jr: TNF-and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274, 784-787, 1996.
18. Van Antwerp, D, Martin, S, Kafri, T, Green, D, and Verma, I: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789, 1996.
19. Osborn, L, Kunkel, S, and Nabel, G: TNF-α and IL-1 stimulate the human immunodeficiency virus enhancer by activation of NF-κB. Proc Natl Acad Sci USA 86, 2336-2340, 1989.
20. Schulze-Osthoff, K, Beyaert, R, Vandevoorde, V, Haegeman, G, and Fiers, W: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12, 3095-3104, 1993.
21. Brown, K, Gerstberger, L, Carlson, L, Franzoso, G, and Siebenlist, U: Control of 1κB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488, 1995.
22. DiDonato, J, Hayakawa, M, Rothwarf, D, Zandi, E, and Karin, M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554, 1997.
23. Jamaluddin, M, Casola, A, Garofalo, R, Han, Y, Elliott, T, et al.: The major component of IκBα proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol 72, 4849-4857, 1998.
24. Beg, A, and Baltimore, D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784, 1996.
25. Wang, C, Mayo, M, Korneluk, R, Goeddel, D, and Baldwin, A, Jr: NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683, 1998.
26. Caldenhoven, E, Liden, J, Wissink, S, Van de Stolpe, A, Raaijmakers, J, et al.: Negative cross-talk between ReIA and the gluocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol 9, 401-412, 1995.
27. Brostjan, C, Anrather, J, Csizmadia, V, Natarajan, G, and Winkler, H: Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J Immunol 158, 3836-3844, 1997.
28. Iwasaki, T, Uehara, Y, Graves, L, Rachie, N, and Bomsztyk, K: Herbamycin A blocks IL-1 induced NF-κB DNA binding activity in lymphoid cell lines. FEBS Lett 298, 240-244, 1992
29. Anderson, M, Staal, F, Gitler, C, Herzenberg, LA, and Herzenberg, L: Separation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Proc Natl Acad Sci USA 91, 11527-11531, 1994.
30. Lee, F, Hagler, J, Chen, Z, and Maniatis, T: Activation of the IκB kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222, 1997.
31. Regnier, C, Song, H, Gao, X, Goeddel, D, Cao, Z, et al.: Identification and characterization of an IκB kinase. Cell 90, 373-383, 1997.
32. Malinin, N, Boldin, M, Kovalenko, A, and Wallach, D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544, 1997.
33. Natarajan, K, Manna, S, Madan, M, Chaturvedi, M, and Aggarwal, B: Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-κB, degradation of IκBα, nuclear translocation of p65 and subsequent gene expression. Arch Biochem Biophys 352, 59-70, 1998.
34. Mahboubi, K, Young, W, and Ferreri, N: Tyrosine phosphatase-dependent/tyrosine kinase independent induction of NF-κB by TNF-α: effects on prostaglandin endoperoxide synthase-2 mRNA accumulation. J Pharmacol Exp Ther 285, 862-868, 1998.
35. Tetsuka, T, Srivastava, S, and Morrison, A: Tyrosine kinase inhibitors, genistein and herbamycin A, do not block IL-1β induced activation of NF-κB in mesangial cells. Biochem Biophys Res Commun 218, 808-812, 1996.
36. Visconti, R, Cerutti, J, Battista, S, Fedele, M, Trapasso, F, et al.: Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene 15, 1987-1994, 1997.
37. Li, J, Westergaard, C, Ghosh, P, and Colburn, N: Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 57, 3569-3576, 1997.
38. Xu, X, Harris, KS, Wang, HJ, Murphy, PA, and Hendrich, S: Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125, 2307-2315, 1995.